Lidocaine Baxter (Lidocaine Hydrochloride)

Lidocaine acts by inhibiting voltage‑gated sodium channels on neuronal membranes. This inhibition prevents the rapid influx of sodium ions that is necessary for the initiation and propagation of action potentials, thereby halting nerve impulse conduction and producing a reversible loss of sensation in the treated area.

The dosage of Lidocaine Baxter is determined by the prescribing clinician based on the specific procedure, patient weight, and clinical context. Healthcare professionals calculate the total amount needed and ensure it does not exceed the recommended maximum dose for intravenous administration.

Safety data for lidocaine in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Clinicians should weigh the potential benefits against any possible risks and consider alternative options when treating pregnant or nursing patients.

To order Lidocaine Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for many short‑procedural applications. Compared with ester‑type agents such as procaine, lidocaine has a lower risk of allergic reactions and a more predictable pharmacokinetic profile, though alternatives like bupivacaine may offer longer lasting anesthesia.

Lidocaine Baxter should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use, and discard any solution that appears discolored or contains particles.

Lidocaine Baxter is administered intravenously by a qualified healthcare professional. The solution is injected directly into a vein or used as part of a nerve block technique, following aseptic technique and appropriate dosing calculations based on the patient’s weight and clinical indication.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias, central nervous system seizures, profound hypotension, respiratory depression, and methemoglobinemia. Prompt recognition and emergency management are essential if any of these events occur during or after administration.

Lidocaine Baxter should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, those with severe cardiac conduction disorders, or individuals who have experienced previous adverse reactions to lidocaine. Clinicians must also consider contraindications related to concurrent medications that may increase toxicity.